Bank of America
CTMX icon

Bank of America’s CytomX Therapeutics CTMX Stock Holding History

Bank of America’s Portfolio CTMX Stock Details CTMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$48M Buy
10,202,785
+9,326,480
+1,064% +$47.3M ﹤0.01% 1625
2025
Q4 		$3.73M Sell
876,305
-128,923
-13% -$490K ﹤0.01% 3608
2025
Q3 		$3.21M Buy
1,005,228
+1,000,457
+20,970% +$2.25M ﹤0.01% 4410
2025
Q2 		$10.8K Sell
4,771
-459,083
-99% -$740K ﹤0.01% 7177
2025
Q1 		$295K Buy
463,854
+461,833
+22,852% +$358K ﹤0.01% 5952
2024
Q4 		$2.08K Sell
2,021
-18,540
-90% -$19.9K ﹤0.01% 7198
2024
Q3 		$24.3K Buy
20,561
+14,817
+258% +$18.8K ﹤0.01% 6707
2024
Q2 		$7.01K Sell
5,744
-72,070
-93% -$143K ﹤0.01% 6956
2024
Q1 		$170K Buy
77,814
+60,035
+338% +$111K ﹤0.01% 5970
2023
Q4 		$27.6K Sell
17,779
-7,786
-30% -$10.2K ﹤0.01% 6726
2023
Q3 		$33K Sell
25,565
-5,697
-18% -$8.97K ﹤0.01% 6604
2023
Q2 		$53.8K Sell
31,262
-8,769
-22% -$14.6K ﹤0.01% 6435
2023
Q1 		$60.4K Sell
40,031
-1,978
-5% -$4.47K ﹤0.01% 6438
2022
Q4 		$67.2K Buy
42,009
+28,921
+221% +$42.8K ﹤0.01% 6387
2022
Q3 		$19K Sell
13,088
-5,165
-28% -$7.95K ﹤0.01% 7048
2022
Q2 		$34K Buy
18,253
+3,548
+24% +$6.79K ﹤0.01% 6995
2022
Q1 		$39K Sell
14,705
-36,402
-71% -$140K ﹤0.01% 7278
2021
Q4 		$221K Buy
51,107
+19,456
+61% +$114K ﹤0.01% 6446
2021
Q3 		$161K Buy
31,651
+6,692
+27% +$35.8K ﹤0.01% 6439
2021
Q2 		$158K Sell
24,959
-22,245
-47% -$173K ﹤0.01% 6247
2021
Q1 		$364K Buy
47,204
+25,925
+122% +$205K ﹤0.01% 5623
2020
Q4 		$140K Sell
21,279
-37,743
-64% -$270K ﹤0.01% 5817
2020
Q3 		$392K Buy
59,022
+27,941
+90% +$207K ﹤0.01% 4894
2020
Q2 		$259K Buy
31,081
+7,532
+32% +$69.9K ﹤0.01% 5070
2020
Q1 		$181K Sell
23,549
-5,077
-18% -$35.4K ﹤0.01% 5141
2019
Q4 		$237K Sell
28,626
-33,067
-54% -$223K ﹤0.01% 5527
2019
Q3 		$455K Sell
61,693
-38,819
-39% -$383K ﹤0.01% 5148
2019
Q2 		$1.13M Sell
100,512
-26,931
-21% -$282K ﹤0.01% 4480
2019
Q1 		$1.37M Buy
127,443
+71,869
+129% +$1.06M ﹤0.01% 4283
2018
Q4 		$839K Buy
55,574
+3,416
+7% +$50.7K ﹤0.01% 4547
2018
Q3 		$965K Sell
52,158
-76,429
-59% -$1.74M ﹤0.01% 4505
2018
Q2 		$2.94M Sell
128,587
-71,077
-36% -$1.82M ﹤0.01% 3659
2018
Q1 		$5.68M Buy
199,664
+78,391
+65% +$2.24M ﹤0.01% 2957
2017
Q4 		$2.56M Buy
121,273
+25,041
+26% +$519K ﹤0.01% 3742
2017
Q3 		$1.75M Sell
96,232
-8,579
-8% -$134K ﹤0.01% 4088
2017
Q2 		$1.63M Buy
104,811
+26,588
+34% +$401K ﹤0.01% 4070
2017
Q1 		$1.35M Sell
78,223
-39,767
-34% -$523K ﹤0.01% 4215
2016
Q4 		$1.3M Buy
117,990
+46,666
+65% +$565K ﹤0.01% 4133
2016
Q3 		$1.12M Buy
71,324
+68,165
+2,158% +$825K ﹤0.01% 4079
2016
Q2 		$33K Buy
3,159
+1,405
+80% +$16K ﹤0.01% 6019
2016
Q1 		$23K Sell
1,754
-252
-13% -$3.5K ﹤0.01% 6082
2015
Q4 		$42K Buy
+2,006
New +$31.7K ﹤0.01% 6113

Other funds holding CTMX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Bank of America's CTMX Position: Q1 2026 in Review

Bank of America increased its CytomX Therapeutics (CTMX) stake by 1,064% in Q1 2026, buying an estimated $47.3M and bringing the position to 10,202,785 shares worth $48M. The position accounts for ﹤0.01% of the portfolio, ranked #1625.

Bank of America first reported a position in CTMX in Q4 2015 and has held it in 42 quarters since. 179 funds tracked by Wall St. Rank hold CTMX as of Q1 2026.

  • Bank of America held 10,202,785 shares of CytomX Therapeutics worth $48M as of Q1 2026.
  • Bank of America bought 9,326,480 CytomX Therapeutics shares in Q1 2026, an estimated $47.3M.
  • CytomX Therapeutics made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #1625 holding.
  • Bank of America first reported a position in CytomX Therapeutics in Q4 2015 and has held it in 42 quarters since.
  • 179 funds tracked by Wall St. Rank held CytomX Therapeutics as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.